BioWorld Today: News to Note-Veloxis Pharmaceuticals A/S

May 23, 2013 - BioWorld Today

Veloxis Pharmaceuticals A/S, of Horsholm, Denmark, said the European Medicines Agency agreed to review its marketing authorization application for LCPTacro to prevent organ rejection in kidney transplant patients. The company expects a decision on the once-daily formulation of the immunosuppressive drug tacrolimus next year. (See BioWorld Today, May 24, 2012.)